2022 Overview

(1)

Statistics at a glance, 2022

Top 5 most frequent cancers Number of new cases

408 661

Number of deaths

242 988

Number of prevalent cases (5-year)

1 018 110

Males Females Both sexes

Population 140 508 390 138 626 115 279 134 505

Incidence

Number of new cancer cases 188 395 220 266 408 661

Age-standardized incidence rate 135.5 141.6 136.9

Risk of developing cancer before the age

of 75 years (cum. risk %) 14.1 14.0 14.0

Top 3 leading cancers (ranked by

cases) Lung

Colorectum Liver

Breast Cervix uteri Ovary

Breast Lung Cervix uteri

Mortality

Number of cancer deaths 128 740 114 248 242 988

Age-standardized mortality rate 93.9 73.9 82.5

Risk of dying from cancer before the age

of 75 years (cum. risk %) 9.9 7.9 8.8

Top 3 leading cancers (ranked by

deaths) Lung

Liver Colorectum

Breast Cervix uteri Ovary

Lung Liver Breast

Prevalence

5-year prevalent cases 397 985 620 125 1 018 110

*

**

*

**

*

0 250 500 1000 Kilometers

Indonesia

**

Males

Lung

Colorectum

Liver

Nasopharynx Prostate Others

Total: 188 395

Number of new cases in 2022, males, all ages

Rank Cancer site Number of cases Percent

1st Lung 29 107 15.4%

2nd Colorectum 21 903 11.6%

3rd Liver 18 314 9.7%

4th Nasopharynx 14 497 7.7%

5th Prostate 13 130 7.0%

- Others 91 444 48.5%

Females

Breast

Cervix uteri

Ovary Colorectum Lung Others

Total: 220 266

Number of new cases in 2022, females, all ages

1st Breast 66 271 30.1%

2nd Cervix uteri 36 964 16.8%

3rd Ovary 15 130 6.9%

4th Colorectum 13 773 6.3%

5th Lung 9 797 4.4%

- Others 78 331 35.6%

Both sexes

Breast

Lung

Cervix uteri

Colorectum Liver Others

Total: 408 661

Number of new cases in 2022, both sexes, all ages

1st Breast 66 271 16.2%

2nd Lung 38 904 9.5%

3rd Cervix uteri 36 964 9.0%

4th Colorectum 35 676 8.7%

5th Liver 23 805 5.8%

- Others 207 041 50.7%

G L O B O C A N 2 0 2 2

INDONESIA

(2)

New cases Deaths 5-year prevalence

Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000)

Breast 66 271 1 41.8 4.4 22 598 3 14.4 1.6 209 748 20.6

Lung 38 904 2 13.4 1.6 34 339 1 11.9 1.5 51 194 5.0

Cervix uteri 36 964 3 23.3 2.4 20 708 4 13.2 1.5 120 940 11.9

Colorectum 35 676 4 12.1 1.4 19 255 5 6.6 0.71 104 235 10.2

Liver 23 805 5 8.0 0.92 23 383 2 7.9 0.91 30 363 3.0

Nasopharynx 18 835 6 6.1 0.70 12 949 6 4.3 0.53 54 281 5.3

NHL 16 175 7 5.5 0.61 9 440 9 3.3 0.36 50 496 5.0

Ovary 15 130 8 9.8 1.0 9 673 8 6.2 0.71 45 711 4.5

Leukaemia 13 959 9 5.2 0.43 10 370 7 3.7 0.34 42 867 4.2

Thyroid 13 761 10 4.5 0.45 2 141 19 0.76 0.07 43 354 4.3

Prostate 13 130 11 10.5 1.2 4 860 12 4.2 0.31 33 051 3.2

Corpus uteri 8 384 12 5.3 0.59 2 454 18 1.6 0.17 29 904 2.9

Bladder 7 381 13 2.6 0.30 3 207 15 1.1 0.11 21 376 2.1

Lip, oral cavity 6 515 14 2.2 0.25 3 546 13 1.2 0.13 16 573 1.6

Brain CNS 5 738 15 2.0 0.18 5 259 11 1.8 0.18 20 134 2.0

Pancreas 5 734 16 2.0 0.24 5 833 10 2.0 0.24 5 781 0.57

Larynx 4 000 17 1.4 0.16 2 525 17 0.87 0.10 10 315 1.0

Stomach 3 852 18 1.3 0.13 3 242 14 1.1 0.11 5 308 0.52

Multiple myeloma 3 289 19 1.2 0.14 2 948 16 1.0 0.12 8 490 0.83

Kidney 2 676 20 0.90 0.11 1 563 20 0.53 0.07 7 459 0.73

Salivary glands 2 436 21 0.80 0.09 1 083 22 0.36 0.04 7 930 0.78

Melanoma 1 716 22 0.60 0.06 774 24 0.27 0.03 5 245 0.52

Oropharynx 1 525 23 0.51 0.05 892 23 0.30 0.03 4 080 0.40

Testis 1 492 24 1.1 0.07 342 29 0.27 0.01 5 368 0.53

Oesophagus 1 382 25 0.48 0.06 1 330 21 0.46 0.06 1 931 0.19

Vulva 1 307 26 0.84 0.09 470 25 0.30 0.03 3 342 0.33

Hodgkin lymphoma 1 294 27 0.44 0.04 373 28 0.13 0.01 4 541 0.45

Penis 1 098 28 0.77 0.08 419 27 0.30 0.03 2 935 0.29

Gallbladder 627 29 0.22 0.02 432 26 0.15 0.01 697 0.07

Vagina 462 30 0.30 0.02 189 31 0.13 0.01 989 0.10

Hypopharynx 292 31 0.10 0.01 160 32 0.05 0.01 555 0.06

Mesothelioma 243 32 0.09 0.01 227 30 0.08 0.01 197 0.02

All cancers 408 661 - - 14.0 242 988 - - 8.8 1 018 110 -

All cancers excl. NMSC 400 820 - - 13.7 240 537 - - 8.7 993 577 -

Incidence, Mortality and Prevalence by cancer site

Data source and methods

Incidence

Country-specific data source: No data

Method: No data: the rates are those of neighbouring countries or registries in the same area

Mortality

Country-specific data source: No data

Method: Estimated from national mortality estimates by modelling, using mortality:incidence ratios derived from survival estimation

Prevalence

Computed using sex-; site- and age-specific incidence to 1-;3- and 5-year prevalence ratios from Nordic countries for the period (2011-2020), and scaled using Human Development Index (HDI) ratios.

41.8 23.3

13.4 12.1 10.5

9.8 8.0

6.1 5.5 5.3 5.2 4.5 2.6

2.2 2.0

0 10 20 30 40 50 60 Breast Cervix uteri Lung Colorectum Prostate Ovary Liver Nasopharynx NHL Corpus uteri Leukaemia Thyroid Bladder Lip, oral cavity Brain CNS

0 10 20 30 40 50 60 14.4

13.2 11.9 6.6 4.2

6.2 7.9 4.3 3.3 1.6

3.7 0.8 1.1 1.2 1.8 Incidence Mortality

ASR (World) incidence and mortality rates, top 15 cancers^**

21.3 15.7

12.9 10.5

9.6 7.3 6.4

4.7 2.9 2.8 2.7

0 10 20 30 40 50 Breast Cervix uteri Lung Colorectum Liver Prostate Ovary Nasopharynx NHL Leukaemia Corpus uteri Bladder Lip, oral cavity Thyroid Larynx

0 10 20 30 40 50

41.8 23.3

6.4 8.9 3.6

9.8 2.8

3.9 4.0 5.3 0.7

1.6 6.2 0.2 Males Females

ASR (World) incidence rates per sex, top 15 cancers^**

* includes non-melanoma skin cancer (NMSC)

** NMSC included in other cancers

Age standardization using world population (see link)

References

Website citation

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).

Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [DD Month YYYY].

Cancer incidence and mortality data

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020:

GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.

2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338.

Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020:

An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.

Page 2